Sprintec and Fasenra drug interactions - a phase IV clinical study of FDA data
Summary:
We study 16,201 people who take Sprintec (ethinyl estradiol; norgestimate) and Fasenra (benralizumab). There is no drug interaction reported.
The study analyzes what interactions people have when they take Sprintec and Fasenra. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Sprintec?
Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.
What is Fasenra?
Fasenra has active ingredients of benralizumab. eHealthMe is studying from 11,804 Fasenra users. Check the latest studies of Fasenra.
No report is found.
Do you take Sprintec and Fasenra?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate and benralizumab (the active ingredients of Sprintec and Fasenra, respectively), and Sprintec and Fasenra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aromasin cause Scarlet Fever? - 2 seconds ago
- Diastat and Convulsion for Girls aged 2-9 - 3 seconds ago
- Miacalcin and Vitamin E drug interactions for women aged 60+ - 7 seconds ago
- Could Augmentin '125' cause C-Reactive Protein Increased? - 7 seconds ago
- Could Lopurin cause Blood Sodium Increased? - 9 seconds ago
- Zoledronic Acid and Abdominal Pain Upper for Men aged 60+ - 11 seconds ago
- Ortho Tri-Cyclen vs. Erythromycin, side effect and effectiveness comparison - 20 seconds ago
- Could Heparin Sodium cause Subarachnoid Haemorrhage? - 22 seconds ago
- Ammonium Lactate and Albuterol drug interactions for women aged 60+ - 34 seconds ago
- Arrhythmias and drugs of ingredients of metamizole - 43 seconds ago